TCL Archive NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients August 12, 1983
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say. June 24, 2005